Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros

Base de dados
Ano de publicação
Tipo de documento
País de afiliação
Intervalo de ano de publicação
1.
Artery ; 22(3): 125-39, 1996.
Artigo em Inglês | MEDLINE | ID: mdl-8893971

RESUMO

OBJECTIVE: We evaluated the effect of parathyroidectomy (PTx) and of calcium supplementation on the pressor response to angiotensin II (Ang II) in conscious rats. STUDY DESIGN: PTx and sham surgery were performed on 10-week-old male Wistar rats. The mean arterial pressure (MAP), heart rate, and the effective pressor dose of Ang II (EPD) which defined as the dose of Ang II required to elicit a rise of 20 mmHg in MAP, were evaluated in PTx and sham operated rats. Intracellular free calcium in platelets was assessed with the fluorescent dye, fura-2 acetoxymethyl ester. In addition, after administering a dose of supplemental calcium chloride, a 10, 20, or 40 mg/rat, we determined the changes in the MAP, EPD, and serum calcium level. RESULTS: The EPD in the PTx rats was significantly lower than the sham operated rats. The serum concentration of calcium in PTx was also significantly lower than the sham operated rats. A statistically significant negative relationship was observed between the EPD and intracellular free calcium in PTx rats. Following administration of 20 mg of calcium chloride (7.4 mg of elemental calcium) to the PTx rats, the EPD returned to the level seen in sham operated rats. CONCLUSION: Results suggest that a depletion of parathyroid hormone is associated with the pressor response to Ang II, and is involved in the regulation of intracellular free calcium.


Assuntos
Angiotensina II/farmacologia , Pressão Sanguínea/efeitos dos fármacos , Cloreto de Cálcio/farmacologia , Cálcio/sangue , Paratireoidectomia , Animais , Plaquetas/efeitos dos fármacos , Plaquetas/metabolismo , Pressão Sanguínea/fisiologia , Relação Dose-Resposta a Droga , Eletrólitos/sangue , Corantes Fluorescentes , Frequência Cardíaca/efeitos dos fármacos , Hematócrito , Masculino , Fosfatos/sangue , Ratos , Ratos Wistar , Valores de Referência , Análise de Regressão
2.
Int J Gynaecol Obstet ; 47(2): 115-20, 1994 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-7843479

RESUMO

OBJECTIVES: Using an angiotensin sensitivity test we carried out a prospective study in an attempt to predict the possible onset of preeclampsia and to prevent it by calcium supplementation (elemental calcium 156 or 312 mg/day per os) and treatment with vitamin D3 (0.5 micrograms/3 day per os). METHOD: We used a study design in which 666 singleton pregnant women were managed with conventional antenatal care and 210 singleton pregnant women were managed with a protocol, together with conventional antenatal care. RESULT: Of the 666 women managed conventionally, 113 (16.9%) developed preeclampsia. However, the incidence of preeclampsia in the 210 women managed on the protocol was lower, at 10.9%. CONCLUSION: Our findings indicate that this protocol for the prediction and prevention of preeclampsia is useful for pregnant women at high risk of developing preeclampsia.


Assuntos
Cálcio/uso terapêutico , Colecalciferol/uso terapêutico , Pré-Eclâmpsia/prevenção & controle , Adulto , Angiotensina II , Pressão Sanguínea/efeitos dos fármacos , Causalidade , Protocolos Clínicos , Feminino , Humanos , Incidência , Paridade , Pré-Eclâmpsia/diagnóstico , Pré-Eclâmpsia/epidemiologia , Gravidez , Gravidez de Alto Risco , Estudos Prospectivos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA